Latest News
View all stories
ScienceMedPage Endocrinology
Obesity Drug Trial Participants Abandon Studies After Identifying Placebo Treatment
Patients in obesity drug trials frequently recognize placebo treatments and withdraw from studies to seek effective GLP-1 medications, creating challenges for clinical trial validity.
LifestyleSelf
GLP-1 Medications Drive Gym Members from Cardio to Weight Training
ScienceMedPage Endocrinology
GLP-1 Drugs Cut Death Risk 28% in Diabetic Cancer Patients with Brain Metastases
RegulatoryEndpoints News
FDA Approves Novo Nordisk's Awiqli as First Weekly Insulin for Type 2 Diabetes
LifestyleMen's Health
Food Companies Market 'GLP-1 Friendly' Labels Without FDA Standards
ScienceSelf
GLP-1 Medications Reduce Depression Risk by 20% Independent of Weight Loss
您的完整治疗旅程
从选择合适的药物到长期维持效果，每个阶段都提供全面、独立的指导。